Measurement of upregulation of inducible nitric oxide synthase in the experimental autoimmune encephalomyelitis model using a positron emitting radiopharmaceutical

Nitric Oxide - Biology and Chemistry

Volumn 1, Issue 3, 1997, Pages 263-267

  Zhang, Jian ^a,b   Cross, Anne H ^b   McCarthy, Timothy J ^a   Welch, Michael J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Encephalomyelitis; Enzyme systems; Multiple sclerosis; Nitric oxide synthase; Positron emission tomography (PET); Radiopharmaceutical

Indexed keywords

NITRIC OXIDE SYNTHASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME REGULATION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031408099     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1997.0120     Document Type: Article

References (17)

1. Fowler J. S., Volkow N. D., Wolf A. P. Nuclear Imaging in Drug Discovery, Development, and Approval. 1993;Birkhäuser, Boston. p. 179-200.
2. Kerwin J. F. K. Jr., Heller M. The arginine-nitric oxide pathway: A target for new drugs. Med. Res. Rev. 14:1994;23-74.
3. Kerwin J. F. K. Jr., Lancaster J. R. Jr., Feldman P. L. Nitric oxide: A new paradigm for second messengers. J. Med. Chem. 38:1995;4343-4362.
4. Moncada S., Higgs A. TheL. N. Engl. J. Med. 329:1993;2002-2012.
5. 18. J. Med. Chem. 39:1996;5110-5118.
6. Evans T., Carpenter A., Cohen J. Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver. Proc. Natl. Acad. Sci. USA. 89:1992;5361-5365.
7. Knowles R. G., Merrett M., Salter M., Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270:1990;833-836.
8. Alvord E. D., Kies M. W., Suckling A. J. Experimental allergic encephalomyelitis: A useful model for multiple sclerosis. Prog. Clin. Biol. Res. 146:1984;1-554.
9. Raine C. S. Biology of disease: The analysis of autoimmune demyelination: Its impact on multiple sclerosis. Lab. Invest. 50:1984;608-635.
10. Hooper D. C., Ohnishi S. T., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;5312-5316.
11. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., Dietzschold B. In vivo. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
12. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
13. Cross A. H., Girard T. J., Giacoletto K. S., Evans R. J., Keeling R. M., Lin R. F., Trotter J. L., Karr R. W. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. Invest. 95:1995;2783-2789.
14. ++. J. Immunol. 127:1981;1420-1423.
15. 18. Appl. Radiat. Isotopes. 40:1989;455-460.
16. Cross A. H., Keeling R. M., Goorha S., San M., Rodi C., Wyatt P. S., Manning P. T., Misko T. P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153.
17. Waldburger K. E., Hastings R. C., Schaub R. G., Goldman S. J., Leonrad J. P. Adoptive transfer of experimental allergic encephalomyelitis afterin vitro. Am. J. Physiol. 148:1996;375-382.